Xenon Pharma

Forecast & Rating19 analysts currently cover Xenon Pharma, with about 94.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $71.94, about 103.6% upside from the current price of $35.34. Price targets range from $46.00 to $90.00 — a wide spread, showing clear disagreement over just how much Xenon Pharma can rise. Historically, about 53.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Xenon Pharma closely still see room for the stock to rise. Data as of Oct 23, 2026; for reference only and not investment advice.